— Know what they know.
Not Investment Advice

INSD OTC

Instadose Pharma Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -90.9% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $53193 mcap · 402M float · 0.0002% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$3K +3454.6% ▲
5Y CAGR: -24.4%
Total Liabilities
$127K -38.6% ▼
5Y CAGR: +117.1%
Shareholders Equity
-$127K -18.8% ▼
Cash & Investments
$0 -100.0% ▼
Total Debt
$0 +0.0% ▲
Net Debt
$0 +100.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$1K$133$84$84$0
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$1K$133$84$84$0
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$1K$133$84$84$0
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$2K$0$0$0$3K
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$2K$0$0$0$3K
Total Assets$1K$133$84$84$3K
— Liabilities —
Accounts Payable$2K$1K$1K$439$11K
Short-Term Debt$0$0$56K$0$0
Deferred Revenue-$1$1-$56K$0$0
Other Current Liabilities$0$0$0$207K-$80K
Total Current Liabilities$17K$45K$75K$207K$127K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$13K$34K$0$0$0
Total Liabilities$17K$45K$107K$207K$127K
— Equity —
Common Stock$97K$100K$104K$6K$6K
Retained Earnings-$44K-$76K-$131K-$82K-$445K
Accumulated OCI$0$0$0$0-$2K
Total Stockholders Equity-$15K-$44K-$98K-$107K-$127K
Total Liabilities & Equity$1K$133$84$50$3K
— Key Metrics —
Total Debt$12K$33K$56K$0$0
Net Debt$11K$33K$56K-$84$0
Total Investments$2K$0$0$0$3K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms